Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [41] Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies
    Huang, Tian-bao
    Yan, Yang
    Guo, Zhui-feng
    Zhang, Xiao-long
    Liu, Huan
    Geng, Jiang
    Yao, Xu-dong
    Zheng, Jun-hua
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (09) : 1715 - 1728
  • [42] Pretreatment prostate-specific antigen density as a predictor of biochemical recurrence in patients with prostate cancer: a meta-analysis
    Cui, Feilun
    Qiu, Yue
    Xu, Wei
    Zou, Chen
    Fan, Yu
    BMC CANCER, 2024, 24 (01)
  • [43] Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
    Islam, Md. Mohaimenul
    Poly, Tahmina Nasrin
    Walther, Bruno Andreas
    Yang, Hsuan-Chia
    Li, Yu-Chuan
    CANCERS, 2020, 12 (03)
  • [44] The Prognostic Effect of Statin Use on Urologic Cancers An Updated Meta-Analysis of 35 Observational Studies
    Luo, You
    She, Dong-Li
    Xiong, Hu
    Fu, Sheng-Jun
    Yang, Li
    MEDICINE, 2015, 94 (36)
  • [45] Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis
    Takemura, Lucas Seiti
    Costa, Pedro Henrique Peixoto
    Claros, Oliver Rojas
    Tourinho-Barbosa, Rafael Rocha
    Teles, Saulo Borborema
    Sanchez-Salas, Rafael
    Nahar, Bruno
    Olivares, Ruben
    Montagna, Erik
    Lemos, Gustavo Caserta
    Bianco, Bianca
    Carneiro, Arie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 449.e1 - 449.e11
  • [46] Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
    Jin, Kun
    Qiu, Shi
    Liao, Xin-Yang
    Zheng, Xiao-Nan
    Tu, Xiang
    Tang, Lian-Sha
    Yang, Lu
    Wei, Qiang
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (02) : 217 - 221
  • [47] Management of biochemical recurrence after primary localized therapy for prostate cancer
    Darwish, Oussama M.
    Raj, Ganesh V.
    FRONTIERS IN ONCOLOGY, 2012, 2 : 1 - 6
  • [48] Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation Therapy
    Gutt, Ruchika
    Tonlaar, Nathan
    Kunnavakkam, Rangesh
    Karrison, Theodore
    Weichselbaum, Ralph R.
    Liauw, Stanley L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2653 - 2659
  • [49] Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review
    Xu, Meng-Yao
    An, Ye
    Liu, Chen-Qian
    Xu, Jin-Zhou
    Zhong, Xing-Yu
    Zeng, Na
    Sun, Jian-Xuan
    Xia, Qi-Dong
    Wang, Shao-Gang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [50] Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis
    Park, H. S.
    Schoenfeld, J. D.
    Mailhot, R. B.
    Shive, M.
    Hartman, R. I.
    Ogembo, R.
    Mucci, L. A.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1427 - 1434